Effect of ranolazine as add‐on therapy in type 2 diabetic dyslipidaemia patients: A randomised open‐label trial
Gespeichert in:
| Veröffentlicht in: | International journal of clinical practice (Esher) 2021-04, Vol.75 (4), p.e14016-n/a |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | n/a |
|---|---|
| container_issue | 4 |
| container_start_page | e14016 |
| container_title | International journal of clinical practice (Esher) |
| container_volume | 75 |
| creator | Ravula, Sahithya Ravali Karunanidhi Santhana, Lakshmi Thangavel Mahalingam, Vijayakumar Janardanan Subramonia, Kumar |
| description | |
| doi_str_mv | 10.1111/ijcp.14016 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2504354810</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2502875475</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3576-58796fab275ae1bc7872adc55a9df5fba6212f7df732453c35b3967e5e603c6a3</originalsourceid><addsrcrecordid>eNp9kb1uFDEQxy0EIh_Q8ADIEg2KtMEfa3uPLjoFSBQJCqhXs_ZY-ORbL_aeoqXiEXhGniQ-LklBwTQzxW9-Gs2fkFecnfNa78LGTue8ZVw_IcfctKLhouVP6yx11ygm-RE5KWXDmFCqY8_JkZRGCbHSx6Rceo92psnTDGOK8DOMSKFQcO7Pr99ppPN3zDAtNNRxmZAK6gIMOAdL3VJimIID3AagE8wBx7m8pxd7l0vbUNDRNOFYTbHuRDrnAPEFeeYhFnx530_Jtw-XX9efmpvPH6_WFzeNlcroRnVmpT0MwihAPljTGQHOKgUr55UfQAsuvHHeSNEqWZcGudIGFWomrQZ5St4evFNOP3ZY5r5eZDFGGDHtSi8Ua6VqO84q-uYfdJN2eazX7SnRGdUaVamzA2VzKiWj76cctpCXnrN-H0W_j6L_G0WFX98rd8MW3SP68PsK8ANwGyIu_1H1V9frLwfpHYvhlXg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2502875475</pqid></control><display><type>article</type><title>Effect of ranolazine as add‐on therapy in type 2 diabetic dyslipidaemia patients: A randomised open‐label trial</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Ravula, Sahithya Ravali ; Karunanidhi Santhana, Lakshmi ; Thangavel Mahalingam, Vijayakumar ; Janardanan Subramonia, Kumar</creator><creatorcontrib>Ravula, Sahithya Ravali ; Karunanidhi Santhana, Lakshmi ; Thangavel Mahalingam, Vijayakumar ; Janardanan Subramonia, Kumar</creatorcontrib><identifier>ISSN: 1368-5031</identifier><identifier>EISSN: 1742-1241</identifier><identifier>DOI: 10.1111/ijcp.14016</identifier><identifier>PMID: 33752296</identifier><language>eng</language><publisher>England: Hindawi Limited</publisher><subject>Acetanilides ; Diabetes mellitus ; Diabetes Mellitus, Type 2 - complications ; Diabetes Mellitus, Type 2 - drug therapy ; Dyslipidemia ; Dyslipidemias - drug therapy ; Humans ; Metabolic disorders ; Ranolazine - therapeutic use</subject><ispartof>International journal of clinical practice (Esher), 2021-04, Vol.75 (4), p.e14016-n/a</ispartof><rights>2021 John Wiley & Sons Ltd</rights><rights>Copyright © 2021 John Wiley & Sons Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3576-58796fab275ae1bc7872adc55a9df5fba6212f7df732453c35b3967e5e603c6a3</citedby><cites>FETCH-LOGICAL-c3576-58796fab275ae1bc7872adc55a9df5fba6212f7df732453c35b3967e5e603c6a3</cites><orcidid>0000-0002-5159-5142</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fijcp.14016$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fijcp.14016$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,777,781,1412,27905,27906,45555,45556</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33752296$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ravula, Sahithya Ravali</creatorcontrib><creatorcontrib>Karunanidhi Santhana, Lakshmi</creatorcontrib><creatorcontrib>Thangavel Mahalingam, Vijayakumar</creatorcontrib><creatorcontrib>Janardanan Subramonia, Kumar</creatorcontrib><title>Effect of ranolazine as add‐on therapy in type 2 diabetic dyslipidaemia patients: A randomised open‐label trial</title><title>International journal of clinical practice (Esher)</title><addtitle>Int J Clin Pract</addtitle><subject>Acetanilides</subject><subject>Diabetes mellitus</subject><subject>Diabetes Mellitus, Type 2 - complications</subject><subject>Diabetes Mellitus, Type 2 - drug therapy</subject><subject>Dyslipidemia</subject><subject>Dyslipidemias - drug therapy</subject><subject>Humans</subject><subject>Metabolic disorders</subject><subject>Ranolazine - therapeutic use</subject><issn>1368-5031</issn><issn>1742-1241</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kb1uFDEQxy0EIh_Q8ADIEg2KtMEfa3uPLjoFSBQJCqhXs_ZY-ORbL_aeoqXiEXhGniQ-LklBwTQzxW9-Gs2fkFecnfNa78LGTue8ZVw_IcfctKLhouVP6yx11ygm-RE5KWXDmFCqY8_JkZRGCbHSx6Rceo92psnTDGOK8DOMSKFQcO7Pr99ppPN3zDAtNNRxmZAK6gIMOAdL3VJimIID3AagE8wBx7m8pxd7l0vbUNDRNOFYTbHuRDrnAPEFeeYhFnx530_Jtw-XX9efmpvPH6_WFzeNlcroRnVmpT0MwihAPljTGQHOKgUr55UfQAsuvHHeSNEqWZcGudIGFWomrQZ5St4evFNOP3ZY5r5eZDFGGDHtSi8Ua6VqO84q-uYfdJN2eazX7SnRGdUaVamzA2VzKiWj76cctpCXnrN-H0W_j6L_G0WFX98rd8MW3SP68PsK8ANwGyIu_1H1V9frLwfpHYvhlXg</recordid><startdate>202104</startdate><enddate>202104</enddate><creator>Ravula, Sahithya Ravali</creator><creator>Karunanidhi Santhana, Lakshmi</creator><creator>Thangavel Mahalingam, Vijayakumar</creator><creator>Janardanan Subramonia, Kumar</creator><general>Hindawi Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7T5</scope><scope>7TK</scope><scope>7TS</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-5159-5142</orcidid></search><sort><creationdate>202104</creationdate><title>Effect of ranolazine as add‐on therapy in type 2 diabetic dyslipidaemia patients: A randomised open‐label trial</title><author>Ravula, Sahithya Ravali ; Karunanidhi Santhana, Lakshmi ; Thangavel Mahalingam, Vijayakumar ; Janardanan Subramonia, Kumar</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3576-58796fab275ae1bc7872adc55a9df5fba6212f7df732453c35b3967e5e603c6a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Acetanilides</topic><topic>Diabetes mellitus</topic><topic>Diabetes Mellitus, Type 2 - complications</topic><topic>Diabetes Mellitus, Type 2 - drug therapy</topic><topic>Dyslipidemia</topic><topic>Dyslipidemias - drug therapy</topic><topic>Humans</topic><topic>Metabolic disorders</topic><topic>Ranolazine - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ravula, Sahithya Ravali</creatorcontrib><creatorcontrib>Karunanidhi Santhana, Lakshmi</creatorcontrib><creatorcontrib>Thangavel Mahalingam, Vijayakumar</creatorcontrib><creatorcontrib>Janardanan Subramonia, Kumar</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Physical Education Index</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of clinical practice (Esher)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ravula, Sahithya Ravali</au><au>Karunanidhi Santhana, Lakshmi</au><au>Thangavel Mahalingam, Vijayakumar</au><au>Janardanan Subramonia, Kumar</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of ranolazine as add‐on therapy in type 2 diabetic dyslipidaemia patients: A randomised open‐label trial</atitle><jtitle>International journal of clinical practice (Esher)</jtitle><addtitle>Int J Clin Pract</addtitle><date>2021-04</date><risdate>2021</risdate><volume>75</volume><issue>4</issue><spage>e14016</spage><epage>n/a</epage><pages>e14016-n/a</pages><issn>1368-5031</issn><eissn>1742-1241</eissn><cop>England</cop><pub>Hindawi Limited</pub><pmid>33752296</pmid><doi>10.1111/ijcp.14016</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0002-5159-5142</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1368-5031 |
| ispartof | International journal of clinical practice (Esher), 2021-04, Vol.75 (4), p.e14016-n/a |
| issn | 1368-5031 1742-1241 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2504354810 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
| subjects | Acetanilides Diabetes mellitus Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - drug therapy Dyslipidemia Dyslipidemias - drug therapy Humans Metabolic disorders Ranolazine - therapeutic use |
| title | Effect of ranolazine as add‐on therapy in type 2 diabetic dyslipidaemia patients: A randomised open‐label trial |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T00%3A38%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20ranolazine%20as%20add%E2%80%90on%20therapy%20in%20type%202%20diabetic%20dyslipidaemia%20patients:%20A%20randomised%20open%E2%80%90label%20trial&rft.jtitle=International%20journal%20of%20clinical%20practice%20(Esher)&rft.au=Ravula,%20Sahithya%20Ravali&rft.date=2021-04&rft.volume=75&rft.issue=4&rft.spage=e14016&rft.epage=n/a&rft.pages=e14016-n/a&rft.issn=1368-5031&rft.eissn=1742-1241&rft_id=info:doi/10.1111/ijcp.14016&rft_dat=%3Cproquest_cross%3E2502875475%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2502875475&rft_id=info:pmid/33752296&rfr_iscdi=true |